US 11,666,630 B2
Polypeptides for managing viral infections
Sanil George, Thimvananthapuram (IN); Joshy Jacob, Snellville, GA (US); David Holthausen, Atlanta, GA (US); Song Hee Lee, Atlanta, GA (US); and Jessica Shartouny, Atlanta, GA (US)
Assigned to Emory University, Atlanta, GA (US); and Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram (IN)
Filed by EMORY UNIVERSITY, Atlanta, GA (US); and RAJIV GANDHI CENTRE FOR BIOTECHNOLOGY, Thiruvananthapuram (IN)
Filed on Dec. 18, 2020, as Appl. No. 17/127,161.
Application 17/127,161 is a division of application No. 16/469,119, granted, now 10,898,544, previously published as PCT/US2017/064330, filed on Dec. 1, 2017.
Claims priority of provisional application 62/466,066, filed on Mar. 2, 2017.
Claims priority of provisional application 62/433,490, filed on Dec. 13, 2016.
Prior Publication US 2021/0138029 A1, May 13, 2021
Int. Cl. A61K 38/17 (2006.01); A61K 38/46 (2006.01); A61K 38/00 (2006.01); A61K 45/06 (2006.01); A61P 31/16 (2006.01); C07K 14/46 (2006.01); C12N 15/00 (2006.01)
CPC A61K 38/17 (2013.01) [A61K 38/46 (2013.01); A61K 45/06 (2013.01); A61P 31/16 (2018.01); C07K 14/463 (2013.01); C12N 15/00 (2013.01); A61K 38/00 (2013.01)] 5 Claims
 
1. An isolated polypeptide consisting of the amino acid sequence
 
 (SEQ ID NO: 1)
 
 SMLLLFFLGTISLSLCQDDQERC,
 
 
 
 (SEQ ID NO: 56)
 
 SMLLLFFLGTISLSLCQ,
 
 
 
 (SEQ ID NO: 57)
 
 PMLLLFFLGTISLSLCQ,
 
 or
 
 
 
 (SEQ ID NO: 65)
 
 LLFFLGTISLSLCQDDQERC,
wherein the polypeptide is acetylated or amidated.